CLINICAL TRIAL PROFILE · UPDATED 2026-09-29

Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes

NCT07279194 · Phase 3 · Recruiting

PHASEPhase 3

STATUSRecruiting

ENROLLMENT825

EST. COMPLETION2026-09-20

Conditions

Obesity & Overweight

Interventions

HDM1005 1HDM1005 2Placebo

Study details

SPONSORHangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

START DATE2025-10-14

Related company profiles

Huadong Medicine

000963.SZ

Primary source

ClinicalTrials.gov record NCT07279194 ↗

Trial status and dates can change. Confirm enrollment and eligibility against the linked ClinicalTrials.gov record.

Evidence & limits

Source: Open the source record

Record identifier: NCT07279194
Event / action date: Not separately retained
Source update date: Not separately retained
Platform retrieval / processing date: Not separately retained

What it supports. Study information reported by the sponsor or investigator, including status, phase, enrollment, and recorded dates.

Limits. Registration or completion does not establish clinical success or approval. Sponsor-name associations can be ambiguous. Dates may be estimated; verify the live study record.

Connection basis. Company sponsor aliases and normalized lead-sponsor containment; the NCT identifier identifies the study.

What this record means · Report an issue with this record